Histone Deacetylases and Their Inhibitors: Classification, Clinical Development, and FDA-Approved Therapeutic Indications
Histone deacetylases (HDACs) are vital regulators of gene expression and chromatin structure. Their abnormal overactivity has been closely linked to the progression of various solid tumors, making them a significant focus of cancer research. HDAC inhibitors (HDACis) have shown clinical promise, particularly in the trea...